The effect of nutritional support on nutritional status, quality of life, and survival in cancer patients receiving systemic anticancer therapy
- 作者: Obukhova O.1, Kurmukov I.1, Ryk A.2
-
隶属关系:
- N.N. Blokhin National Medical Research Center of Oncology
- N.V. Sklifosovsky Research Institute of Emergency Medicine
- 期: 卷 3, 编号 1 (2022)
- 页面: 50-61
- 栏目: Reviews
- URL: https://journals.rcsi.science/2658-4433/article/view/104771
- DOI: https://doi.org/10.17816/clinutr104771
- ID: 104771
如何引用文章
详细
Malnutrition, a common problem among cancer patients, due to the direct influence of the tumor and the consequences of specific therapy, negatively affects the patient’s quality of life and is detrimental to the results of anticancer treatment. Nutritional support plays a vital role in systemic drug anticancer therapy; however, malnutrition that develops against a background of malignant neoplasms remains underestimated and receives little attention in clinical practice.
To assess the need for and safety of nutritional support in this context, an analysis of publications in the medical databases e-Library, PubMed, and Medline was performed with an emphasis on assessing the safety and efficacy of NP in the presence of systemic drug antitumor treatment for the period 2003–2022 using the keywords oncology, chemotherapy, nutritional support, omega-3 fatty acids, and glutamine.
The obtained data show that patients with cancer have anorexia-cachexia syndrome, leading to the development of sarcopenia, which negatively affects the results of specific therapy. Timely appointment of nutritional support significantly improves the results of treatment, as well as quality of life, and increases the survival rate in patients receiving non-surgical anticancer therapy; moreover, nutritional support administered in parallel with anticancer drug therapy improves treatment results.
作者简介
Olga Obukhova
N.N. Blokhin National Medical Research Center of Oncology
编辑信件的主要联系方式.
Email: obukhova0404@yandex.ru
ORCID iD: 0000-0003-0197-7721
SPIN 代码: 6876-7701
MD, Cand. Sci. (Med.)
俄罗斯联邦, MoscowIldar Kurmukov
N.N. Blokhin National Medical Research Center of Oncology
Email: kurmukovia@gmail.com
ORCID iD: 0000-0001-8463-2600
SPIN 代码: 3692-5202
MD, Cand. Sci. (Med.)
俄罗斯联邦, MoscowAlla Ryk
N.V. Sklifosovsky Research Institute of Emergency Medicine
Email: alla-ryk@yandex.ru
ORCID iD: 0000-0002-3968-3713
SPIN 代码: 3984-7800
MD, Cand. Sci. (Med.)
俄罗斯联邦, Moscow参考
- Molfino A, Gioia G, Fanelli RF, Laviano A. Contribution of neuroinflammation to the pathogenesis of cancer cachexia. Mediators Inflamm. 2015;2015:801685. doi: 10.1155/2015/801685
- Ni J, Zhang L. Cancer cachexia: definition, staging, and emerging treatments. Cancer Manag Res. 2020;12:5597–5605. doi: 10.2147/CMAR.S261585
- Cederholm T, Jensen G, Correia MI, et al. GLIM criteria for the diagnosis of malnutrition ― A consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019; 10(1):207–217. doi: 10.1002/jcsm.12383
- Obukhova OA, Kurmukov IA, Kashiya SR. Diagnosis and treatment of iron deficiency anemia in oncology. Oncogynecology. 2014;(2):67–76. (In Russ).
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–423. doi: 10.1093/ageing/afq034
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Writing group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601. doi: 10.1093/ageing/afz046
- Obukhova OA, Bagrova SG, Besova NS, et al. Evaluation of the nutritional status of patients with inoperable gastric cancer at the time of initiation of anticancer treatment. Preliminary results of a prospective observational study. Difficult Patient. 2018;16(6):6–11. (In Russ).
- Shachar SS, Deal AM, Weinberg M, et al. Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy. Clin Cancer Res. 2017;23(3):658–665. doi: 10.1158/1078-0432.CCR-16-0940
- Sealy MJ, Dechaphunkul T, van der Schans CP, et al. Low muscle mass is associated with early termination of chemotherapy related to toxicity in patients with head and neck cancer. Clin Nutr. 2020;39(2):501–509. doi: 10.1016/j.clnu.2019.02.029
- Langius JA, Bakker S, Rietveld DH, et al. Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer. 2013;109(5):1093–1099. doi: 10.1038/bjc.2013.458
- Findlay M, White K, Stapleton N, Bauer J. Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis. Clin Nutr. 2021;40(4):1711–1718. doi: 10.1016/j.clnu.2020.09.017
- Sytov AV, Leiderman IN, Lomidze SV, et al. Practical recommendations on nutritional support for cancer patients. Practical recommendations of RUSSCO. Malignant Tumors. 2019;9(3s2): 639–647. (In Russ). doi: 10.18027/2224-5057-2019-9-3s2-639-647
- Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: clinical nutrition in cancer. Clin Nutr. 2021;40(5): 2898–2913. doi: 10.1016/j.clnu.2021.02.005
- Van der Werf A, Langius JA, Beeker A, et al. The effect of nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: A randomized controlled trial. Clin Nutr. 2020;39(10):3005–3013. doi: 10.1016/j.clnu.2020.01.009
- Obukhova OA, Snegovoy AV, Kurmukov IA, et al. The nutritional status of oncological patient prior to antitumor treatment: single-center prospective observational study. Clinical Nutrition Metabolism. 2020;1(4):178–189. (In Russ). doi: 10.17816/clinutr64707
- Khoronenko V, Sergienko AD, Mandryka EA, et al. Assessment of nutritional status in cancer patients. Difficult Patient. 2018;16(5): 22–26. (In Russ).
- Sánchez-Lara K, Turcott JG, Juárez-Hernández E, et al. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial. Clin Nutr. 2014;33(6):1017–1023. doi: 10.1016/j.clnu.2014.03.006
- Dechaphunkul T, Arundon T, Raungkhajon P, et al. Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: a phase II randomized, double-blind study. Clin Nutr. 2022;41(2):433–440. doi: 10.1016/j.clnu.2021.12.035
- Obukhova OA, Bagrova SG, Besova NS, et al. The influence of additional enteral nutrition with a high content of protein and ω-3 fatty acids on the nutritional status and functional state during chemotherapy in patients with gastric cancer. Nutrition Issues. 2018;87(S5):106–107. (In Russ). doi: 10.24411/0042-8833-2018-10200
- Li T, Lv J, Zhu G, et al. Enteral nutrition to improve nutritional status, treatment tolerance, and outcomes in patients with esophageal cancer undergoing concurrent chemoradiotherapy (CCRT): results of a prospective, randomized, controlled, multicenter trial (NCT 02399306). J Clin Oncol. 2017;35(15 Suppl.):4033–4033. doi: 10.1200/JCO.2017.35.15_SUPPL.4033
- Belyaeva LE, Pavlyukevich AN. Early programming of human diseases and preventive use of nutraceuticals: focus on fish oils. Literature review. Part 2. Bulletin of Vitebsk State Medical University. 2019;18(5):12–25. doi: 10.22263/2312-4156.2019.5.12
- Kreymann KG, Heyland DK, de Heer G, Elke G. Intravenous fish oil in critically ill and surgical patients ― historical remarks and critical appraisal. Clin Nutr. 2018;37(3):1075–1081. doi: 10.1016/j.clnu.2017.07.006
- Fietkau R, Lewitzki V, Kuhnt T, et al. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial. Cancer. 2013;119(18):3343–3353. doi: 10.1002/cncr.28197
- Sánchez-Lara K, Turcott JG, Juárez-Hernández E, et al. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial. Clin Nutr. 2014;33(6):1017–1023. doi: 10.1016/j.clnu.2014.03.006
- Anderson PM, Lalla RV. Glutamine for Amelioration of Radiation and Chemotherapy Associated Mucositis during Cancer Therapy. Nutrients. 2020;12(6):1675. doi: 10.3390/nu12061675
- Piccirillo N, De Matteis S, Laurenti L, et al. Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica. 2003;88(2):192–200.
- Lalla RV, Bowen J, Barasch A, et al. Mucositis guidelines leadership group of the multinational association of supportive care in cancer and international society of oral oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10): 1453–1461. doi: 10.1002/cncr.28592
- Chattopadhyay S, Saha A, Azam M. Role of oral glutamine in alleviation and prevention of radiation-induced oral mucositis: a prospective randomized study. South Asian J Cancer. 2014;3(1): 8–12. doi: 10.4103/2278-330X.126501
- Tsujimoto T, Yamamoto Y, Wasa M, et al. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial. Oncol Rep. 2015;33(1):33–39. doi: 10.3892/or.2014.3564
- Peterson DE, Jones JB, Petit RG. Randomized, placebo-controlled trial of saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer. 2007;109(2):322–331. doi: 10.1002/cncr.22384
- Peng T, Lin H, Yang L, Wu T. Effectiveness of glutamine in the management of oral mucositis in cancer patients: a meta-analysis of randomized controlled trials. Support Care Cancer. 2021;29(8): 4885–4892. doi: 10.1007/s00520-021-06060-9